lupus nephritis

Freely FilteredNephrology Times | April 22, 2025

This Freely Filtered episode discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.

Charlotte RobinsonNephrology Times | February 20, 2025

Researchers studied osteoporosis prevalence and risk factors in Chinese patients with lupus nephritis.

Charlotte RobinsonNephrology Times | December 23, 2024

The American College of Rheumatology issued a summary of a new guideline for lupus nephritis.

Charlotte RobinsonNephrology Times | November 13, 2024

The Lupus Foundation of America will honor Brad H. Rovin, MD, and Alí Duarte-García, MD, at the Evelyn V. Hess Reception.

Charlotte RobinsonASN Kidney Week 2024 | October 14, 2024

Lupkynis for lupus nephritis is the focus of six accepted abstracts at the American Society of Nephrology Kidney Week 2024.

A patient may have normal creatinine and complements but still have highly active lupus nephritis requiring therapy.